Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
:SHPH
Holding SHPH?
Track your performance easily
SHPH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.58 - $4.94
Previous CloseN/A
Volume45.16K
Average Volume (3M)109.09K
Market Cap
$3.15M
Enterprise Value$5.55M
Total Cash (Recent Filing)$117.15K
Total Debt (Recent Filing)$129.38K
Price to Earnings (P/E)―
Beta0.30
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.20
Shares Outstanding3,664,919
10 Day Avg. Volume85,699
30 Day Avg. Volume109,092
Standard Deviation0.28
R-Squared0.00160
Alpha-0.13
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)222.85
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market Cap1.76
Enterprise Value/Revenue387.84
Enterprise Value/Gross Profit709.70
Enterprise Value/Ebitda-0.78
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Shuttle Pharmaceuticals Holdings, Inc. News
PremiumCompany Announcements
Shuttle Pharmaceuticals Starts Phase 2 Trial for Glioblastoma
PremiumCompany Announcements
Shuttle Pharma Raises $4.5M for Clinical Trials
PremiumMarket News
3 Penny Stocks to Watch Now, 10/31/24
PremiumCompany Announcements
Shuttle Pharmaceuticals Advances Phase 2 Glioblastoma Trial
Options Prices
Currently, No data available
---
Ownership Overview
6.61% Insiders
0.10%
Mutual Funds
― Other Institutional Investors
93.28% Public Companies and
Individual Investors
SHPH FAQ
What was Shuttle Pharmaceuticals Holdings, Inc.’s price range in the past 12 months?
Shuttle Pharmaceuticals Holdings, Inc. lowest stock price was $0.58 and its highest was $4.94 in the past 12 months.
What is Shuttle Pharmaceuticals Holdings, Inc.’s market cap?
Shuttle Pharmaceuticals Holdings, Inc.’s market cap is $3.15M.
When is Shuttle Pharmaceuticals Holdings, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Shuttle Pharmaceuticals Holdings, Inc.’s earnings last quarter?
Currently, no data Available
Is Shuttle Pharmaceuticals Holdings, Inc. overvalued?
According to Wall Street analysts Shuttle Pharmaceuticals Holdings, Inc.’s price is currently Overvalued.
Does Shuttle Pharmaceuticals Holdings, Inc. pay dividends?
Shuttle Pharmaceuticals Holdings, Inc. does not currently pay dividends.
What is Shuttle Pharmaceuticals Holdings, Inc.’s EPS estimate?
Shuttle Pharmaceuticals Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shuttle Pharmaceuticals Holdings, Inc. have?
Shuttle Pharmaceuticals Holdings, Inc. has 3,664,919 shares outstanding.
What happened to Shuttle Pharmaceuticals Holdings, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Shuttle Pharmaceuticals Holdings, Inc.?
Currently, no hedge funds are holding shares in SHPH
---
Company Description
Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.
---
Technical Analysis
---